[{"from": "human", "value": "Provide a brief overview of this molecule. [C][N][C][C@H1][Branch2][Ring1][Ring2][C][=C][Branch1][Ring2][C][Ring1][=Branch1][C][=Branch1][=Branch2][=C][C][=Branch1][Ring2][=C][Ring1][#Branch1][Cl][Cl][C][=C][C][=Branch1][=Branch1][=C][C][=C][Ring1][=Branch1][S][=Branch1][C][=O][=Branch1][C][=O][N][C][C][O][C][C][O][C][C][N][C][=Branch1][C][=O][N][C][C][C][C][N][C][=Branch1][C][=O][N][C][C][O][C][C][O][C][C][N][S][=Branch1][C][=O][=Branch1][C][=O][C][=C][C][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][C@@H1][C][N][Branch1][S][C][C][=C][Ring1][=Branch1][C][=C][Branch1][=Branch1][C][=C][Ring1][=Branch1][Cl][Cl][C]"}, {"from": "gpt", "value": "The molecule is a novel, small molecule medication approved in September 2019 for the treatment of constipation-predominant irritable bowel-syndrome (IBS-C). It was first designed and synthesized in 2012. As an inhibitor of the sodium/hydrogen exchanger isoform 3 (NHE3) transporter, it is the first and currently only medication within its class and therefore exists as a novel alternative in the treatment of IBS-C."}]